Header graphic for print

GT Israel Law Blog

A Window to the Legal World for Israeli Companies

Israeli Medical Device & BioPharma Innovations

Posted in Health Care & FDA, Life Sciences, Medical Technology, Uncategorized

Israeli Medical Device & BioPharma Innovations image

Organized by Israel Ministry of Industry Trade and Labor to the U.S., Greenberg Traurig will be hosting an Israeli Medical Device and Bio-Pharma delegation on Tuesday, December 10th from 8-10 a.m. in the Greenberg Traurig Garden Room, One International Place, 20th floor, Boston, MA.

FDA Guidance for Industry and FDA Staff: Mobile Medical Applications

Posted in Health Care & FDA

On September 25, 2013, the Food and Drug Administration (the “FDA”) released final guidance on the regulatory requirements regarding the introduction of mobile medical applications into the marketplace (the “Final Guidance”). The purpose of the Final Guidance and its Appendices is to assist manufacturers with determining if a product is a mobile medical app and if so the FDA’s expectations for that product. This Alert summarizes some the key components of the Final Guidance.

Fall Breakfast on ‘Technology Transfer Trends’

Posted in General, Health Care & FDA, Medical Technology

On Tuesday, September 24, the CJP Healthcare Innovations Team (HIT) is presenting “Technology Transfer Trends In U.S. and Israel” breakfast seminar on Tuesday, September 24 from 7:15 – 9:00 am at Greenberg Traurig, One International Place in Boston. The three fantastic panelists are:

(1) Catherine Ives from Technology Licensing Officer at MIT;

(2) Issi Rozen from the Broad Institute of Harvard and MIT; and

(3) Tal Shapira from the Weizmann Institute of Science.

Greenberg Traurig is sponsoring the event, and David Dykeman from our Boston office will be the Moderator. See details in the invitation.


Greenberg Traurig Announces Life Sciences & Medical Technology Newsletter

Posted in Health Care & FDA, Life Sciences, Medical Technology

Welcome to the first issue of the Greenberg Traurig Life Sciences & Medical Technology Newsletter, a quarterly collection of articles and Alerts written by GT attorneys and focused on significant life sciences, medical technology and healthcare industry developments.

Alternative Investment Funds – Changes in the EU Regulatory Landscape

Posted in Corporate

We are pleased to share with our readers the GT Alert – — Private Placement of Alternative Investment Funds in the EU: Changing Regulatory Landscape, that details the guidelines of the European Union’s Alternative Investment Fund Managers Directive (AIFMD) and their effect on the regulatory landscape in each EU jurisdiction.

This Alert was prepared by Wietse de Jong and Ilana Haramati, with the assistance of GT offices in London and Warsaw, its highly applicable to investors who are seeking to establish investments funds in each EU jurisdiction in the future.

Greenberg Traurig Shareholder David Schulman Appointed to the Executive Committee of the American-Israel Chamber of Commerce, Southeast Region

Posted in General

GT Israel is pleased to announce that David Schulman, a shareholder in our Atlanta office and an active member of our Israel Practice Group, has been appointed to the Executive Committee of the American-Israel Chamber of Commerce (AICC), Southeast Region. David, a native Hebrew speaker, practices in the firm’s Corporate & Securities Department and provides a variety of commercial and technology-related legal advice and support to companies in Israel and abroad. The AICC, Southeast Region was established in 1992 as a private, not-for-profit organization with the goal of helping companies in Israel and the American Southeast (Georgia, Alabama, North Carolina, South Carolina, Tennessee, and Mississippi) to develop stronger business relationships and explore new market opportunities. Today, with over 500 members, the AICC, Southeast Region is regarded as one of the most successful bi-national business organizations in the U.S. and has helped facilitate over $1 billion in transactions between Israeli and American companies.

Treasury and IRS Postpone the Effective Dates of Several Key FATCA Provisions

Posted in Tax

On July 12th, the IRS issued Notice 2013-43, which postpones the effective dates of several key FATCA provisions. This Notice provides: (i) revised timelines for implementation of FATCA; and (ii) additional guidance concerning the treatment of financial institutions located in jurisdictions that have signed intergovernmental agreements (IGAs) for the implementation of FATCA but have not yet brought those IGAs into force.

The six-month extension provided in Notice 2013-43 is intended to allow Treasury and the IRS, on the one hand, to provide more guidance with respect to implementation of FATCA; and affected taxpayers, on the other hand, to get more clarity as to how to comply with FATCA.

We invite our readers to read the GT AlertTreasury and IRS Postpone the Effective Dates of Several Key FATCA Provisions prepared by Yoram Keinan from our New York office.